Weekly update|Companies|Recruiting|Promote|Post a job

Rocket Pharmaceuticals

Founded: 2015

Location: Cranbury, NJ

Employee range: 50 - 200

Clinical stage: Clin2 (fast track)

Therapy area: Fanconi anemia (ODD)

Drug types: HEM, GEN, RAR, BON, IMM, CVV, MUS

Lead product: RP-L102

Product link: https://rocketpharma.com/our-disease-focus/

Funding: $100M stock Oct 2022; $6.5M grant Apr 2019; $78M stock Apr 2019

rocketpharma.com

linkedin.com

job board

Short description:

Gene Therapies

Drug notes:

RP-L201 Clin2 (fast track) leukocyte adhesion deficiency-1 (ODD); RP-A501 Clin1 (fast track) Danon disease (ODD); RP-L301 Clin1 (fast track) pyruvate kinase deficiency (ODD); RP-A601 Clin0 PKP2-ACM (ODD, FT); BAG3 RD cardiovascular

Long description:

Rocket Pharmaceuticals is a clinical-stage company developing gene therapy treatments for rare childhood disorders. Life-threatening childhood disorders such as Fanconi Anemia, Danon Disease and Leukocyte Adhesion Deficiency are caused by genetic mutations in single genes. Rocket is developing therapies that directly target these mutations in affected cell types using both adeno-associated viral vectors and lentiviral vectors. Rocket’s state-of-the-art laboratories are built for designing, optimizing and advancing candidate therapeutics to clinical stage development.

Jobs:

Clinical Manufacturing Associate I

Cranbury, NJ|9 days ago